KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 152 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $15,000 | -6.2% | 1,500 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $16,000 | -30.4% | 1,500 | 0.0% | 0.01% | -36.4% |
| Q4 2020 | $23,000 | +4.5% | 1,500 | 0.0% | 0.01% | -26.7% |
| Q3 2020 | $22,000 | -8.3% | 1,500 | 0.0% | 0.02% | +25.0% |
| Q2 2020 | $24,000 | -17.2% | 1,500 | 0.0% | 0.01% | -20.0% |
| Q1 2020 | $29,000 | 0.0% | 1,500 | 0.0% | 0.02% | +50.0% |
| Q4 2019 | $29,000 | +107.1% | 1,500 | 0.0% | 0.01% | +100.0% |
| Q3 2019 | $14,000 | +55.6% | 1,500 | 0.0% | 0.01% | +66.7% |
| Q2 2019 | $9,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $9,000 | -35.7% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $14,000 | -46.2% | 1,500 | 0.0% | 0.01% | -33.3% |
| Q3 2018 | $26,000 | +4.0% | 1,500 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $25,000 | +25.0% | 1,500 | 0.0% | 0.01% | +12.5% |
| Q1 2018 | $20,000 | +42.9% | 1,500 | 0.0% | 0.01% | +60.0% |
| Q4 2017 | $14,000 | -73.6% | 1,500 | -69.2% | 0.01% | -78.3% |
| Q3 2017 | $53,000 | +20.5% | 4,868 | 0.0% | 0.02% | +21.1% |
| Q2 2017 | $44,000 | -30.2% | 4,868 | 0.0% | 0.02% | -32.1% |
| Q1 2017 | $63,000 | +37.0% | 4,868 | 0.0% | 0.03% | +33.3% |
| Q4 2016 | $46,000 | -2.1% | 4,868 | 0.0% | 0.02% | -16.0% |
| Q3 2016 | $47,000 | +42.4% | 4,868 | 0.0% | 0.02% | +47.1% |
| Q2 2016 | $33,000 | -23.3% | 4,868 | 0.0% | 0.02% | -22.7% |
| Q1 2016 | $43,000 | -33.8% | 4,868 | 0.0% | 0.02% | -15.4% |
| Q4 2015 | $65,000 | +27.5% | 4,868 | 0.0% | 0.03% | +18.2% |
| Q3 2015 | $51,000 | -61.4% | 4,868 | 0.0% | 0.02% | -60.0% |
| Q2 2015 | $132,000 | -11.4% | 4,868 | 0.0% | 0.06% | -20.3% |
| Q1 2015 | $149,000 | +192.2% | 4,868 | +255.8% | 0.07% | +165.4% |
| Q4 2014 | $51,000 | +6.2% | 1,368 | 0.0% | 0.03% | -3.7% |
| Q3 2014 | $48,000 | – | 1,368 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |